Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $402,067,000,000 | reported | |
| FY 2024 | 2024-12-31 | $372,809,000,000 | reported | |
| FY 2023 | 2023-12-31 | $357,776,000,000 | reported | |
| FY 2022 | 2022-12-31 | $322,467,000,000 | reported | |
| FY 2021 | 2021-12-31 | $292,111,000,000 | reported | |
| FY 2020 | 2020-12-31 | $268,706,000,000 | reported | |
| FY 2019 | 2019-12-31 | $256,776,000,000 | reported | |
| FY 2018 | 2018-12-31 | $193,919,000,000 | reported | |
| FY 2017 | 2017-12-31 | $184,765,000,000 | reported |
CVS HEALTH Corp · CIK 64803 · Engraved from SEC EDGAR
Twelve months to Jun 30, 2026 · derived
CVS HEALTH Corp is the largest of the 6 covered companies the SEC files under this code, by revenue. SIC 5912
Latest filing Aug 17, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $3.40B | $0.00 | $3.40B | $2.66 | 1.27B sh | +0.9% | 43.5% |
| FY2024 | $3.37B | $3.02B | $6.40B |
| $2.66 |
| 1.26B sh |
| +0.2% |
| 101.1% |
| FY2023 | $3.13B | $2.01B | $5.14B | $2.42 | 1.26B sh | −2.0% | 49.5% |
| FY2022 | $2.91B | $3.50B | $6.41B | $2.20 | 1.28B sh | −2.2% | 47.6% |
| FY2021 | $2.63B | $0.00 | $2.63B | $2.00 | 1.31B sh | +0.1% | 16.7% |
5 managers · Quarter ended Sep 30, 2026All holders ›
0